Biohaven Ltd. (BHVN) Price Prediction & ForecastBHVNBiohaven Ltd.

Alphio's BHVN stock price prediction model matches the current Biohaven Ltd. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $15.71 (-0.22%). The 1-week path is $15.84 (+0.64%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Biohaven Ltd is a good buy right now due to its recent $795 million licensing deal with SK Biopharmaceuticals, which significantly enhances its liquidity and supports R&D initiatives. The stock has shown a strong upward momentum, with a 5-day change of +11.26% and a year-to-date change of +42.16%. However, the company has reported negative net income figures, with a projected loss of -130 million in Q1 2026, indicating ongoing financial challenges. Overall, the positive catalysts from the licensing deal and the potential for future revenue growth outweigh the risks associated with its current financial performance.

Biohaven Ltd. (BHVN) last closed at $15.74, gaining +3.08%. These facts feed the 1-day and 1-week BHVN price prediction above.